悦康药业(688658.SH)：子公司YKYY018雾化吸入剂获得FDA临床试验批准

Core Viewpoint - YKYY018 aerosol inhalation agent has received FDA approval for clinical trials aimed at preventing and treating respiratory syncytial virus (RSV) infections [1] Group 1 - The company, Yuyuan Pharmaceutical (688658.SH), announced that its wholly-owned subsidiary, Beijing Yuyuan Ketech Pharmaceutical Technology Co., Ltd., has obtained a Study May Proceed Letter from the FDA [1] - The IND number for the clinical trial is 178457 [1]